Research Papers:

Na+/H+ exchanger 1 has tumor suppressive activity and prognostic value in esophageal squamous cell carcinoma

Yosuke Ariyoshi, Atsushi Shiozaki _, Daisuke Ichikawa, Hiroki Shimizu, Toshiyuki Kosuga, Hirotaka Konishi, Shuhei Komatsu, Hitoshi Fujiwara, Kazuma Okamoto, Mitsuo Kishimoto, Yoshinori Marunaka and Eigo Otsuji

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2017; 8:2209-2223. https://doi.org/10.18632/oncotarget.13645

Metrics: PDF 1635 views  |   HTML 2079 views  |   ?  


Yosuke Ariyoshi1,*, Atsushi Shiozaki1,*, Daisuke Ichikawa1, Hiroki Shimizu1, Toshiyuki Kosuga1, Hirotaka Konishi1, Shuhei Komatsu1, Hitoshi Fujiwara1, Kazuma Okamoto1, Mitsuo Kishimoto2, Yoshinori Marunaka3,4, Eigo Otsuji1

1Division of Digestive Surgery, Department of Surgery, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan

2Department of Pathology, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan

3Department of Molecular Cell Physiology and Bio-Ionomics, Graduate School of Medical Science,Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan

4Japan Institute for Food Education and Health, St. Agnes’ University, Kyoto 602-8013, Japan

*These authors contributed equally to this work

Correspondence to:

Atsushi Shiozaki, email: [email protected]

Keywords: esophageal squamous cell carcinoma, Na+/H+ exchanger 1, epithelial-mesenchymal transition, prognosis, Notch signaling

Received: March 29, 2016     Accepted: October 21, 2016     Published: November 26, 2016


Na+/H+ exchanger 1 (NHE1) is a plasma membrane transporter that controls intracellular pH and regulates apoptosis and invasion in various cancer cells. However, the function of NHE1 in esophageal squamous cell carcinoma (ESCC) cells and the relationship between the expression of NHE1 and prognosis of ESCC remain unclear. We found that the knockdown of NHE1 in ESCC cells inhibited apoptosis and promoted cell proliferation, migration, and invasion and showed increases in Snail, β-catenin, and activation of PI3K-AKT signaling, which was consistent with the results obtained from microarrays. Microarrays results suggested that the knockdown of NHE1 suppressed Notch signaling pathway. An immunohistochemical investigation of 61 primary ESCC samples revealed that NHE1 was expressed at higher levels in well-differentiated tumors. The 5-year survival rate was poorer in the NHE1 low group (57.0%) than in the NHE1 high group (82.8%). Multivariate analyses revealed that the weak expression of NHE1 was associated with shorter postoperative survival (hazard ratio 3.570, 95% CI 1.291-11.484, p = 0.0135).We herein demonstrated that the suppression of NHE1 in ESCC may enhance malignant potential by mediating PI3K-AKT signaling and EMT via Notch signaling, and may be related to a poor prognosis in patients with ESCC.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 13645